General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

zoviraxcreamNovember 5 2014

Two batches of Zovirax Eye Ointment (aciclovir 3%) 4.5g have been recalled as a precautionary measure.

The Class 2 Drug Alert has been issued due to batches of pharmaceutical ingredient used in the ointment’s manufacture being found to contain metal particles which were outside the upper specification limit for particle size.

The affected batches are:

•    batch number 3L942 with expiry date October 2018, first issued January 10 2014
•    batch number 3M941 with expiry date January 2019, first issued April 7 2014.

GlaxoSmithKline UK had not received any complaints or adverse reaction reports at the time the alert was issued. Any remaining stocks of the above batches should be returned to the original supplier for credit.

The MHRA says that no alternative batches of this product are currently available and it understands that shortages are already being reported.

UK Medical Information has issued a briefing note relating to alternative treatments for herpes simplex keratitis, saying: “GSK has confirmed that further supplies Zovirax Eye Ointment are unlikely to be available for several months and clinicians are going to need to identify alternative treatments for this condition.

“In primary care, all suspected acute cases of suspected herpes simplex [eye infections] should be urgently referred to the emergency eye service.”

For medical information enquiries contact GlaxoSmithKline Medical Information, on 0800 221 441 or by e-mail at This email address is being protected from spambots. You need JavaScript enabled to view it..

Links:

MHRA Drug Alert

UKMi memo regarding shortage of supply

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...